Expired Tender Belgium ICB TOT Ref. 128739864

Antitumor Drugs Tender in Belgium - 128739864

Tender notice from Belgium, published on 23 Oct 2025.

Executive Summary

The CHIREC has issued a Tender notice for the procurement of a Antitumor Drugs in the Belgium. This Tender notice was published on 23 Oct 2025 and is scheduled to close on 06 Nov 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 128739864, while the tender notice number is 701736-2025 and Register on the platform.

Key facts

Summary
Antitumor Drugs
TOT Ref. No.
128739864
Document Ref. No.
701736-2025
Country
Belgium
Notice type
Tender
Competition
ICB
Publication date
23 Oct 2025
Bid deadline
06 Nov 2025
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Purpose of the contract
The purpose of this contract is to supply pharmacies at the various sites of the contracting authority with anti-tumor drugs, which can be used orally or injected, in different dosages and galenic forms.
Supply delivery locations
Chirec asbl, sites:
•Hospital from Braine-l'Alleud - Waterloo Rue Wayez 35 1420 Braine-l'Alleud
•Delta Hospital Boulevard du Triomphe 201 1160 Brussels
•Sainte-Anne Saint-Remi Clinic Boulevard Jules Graindor 66 1070 Brussels
Allotment
The market is divided into lots as follows:
Lot 1Pemetrexed in solution form to dilute for infusion (L01BA04)
Positions: 100 mg/4 ml, 500 mg/20 ml and 1000 mg/40 ml
Lot 2Paclitaxel in the form of powder for dispersion for injection for infusion (L01CD01) in a formulation of nanoparticles linked to albumin
Post: 100 mg
Lot 3Nilotinib orally (L01EA03)
Posts: capsules at 50 mg, 150 mg and 200 mg
Lot 4Axitinib per os (L01EK01)
Items: 1 mg and 5 mg tablets
Lot 5Obinutuzumab in the form of concentrate for infusion (L01FA03)
Bidders will not be able to in propose an improvement of the offer, nor an additional discount in the event of submission of 2 or more lots.
Options
Nothing.
Variants
Duration of the market
The contract will be concluded for an initial period of 1 year, tacitly renewable 3 times for successive terms of 1 year, covering ains...
Document Type: Contract Notice

Reference Number: PPP0J5-444/5255/Chirec-2025-023

Contract Type: supplies

Authority Type: body-pl

Doc Title: Antitumoraux

Dispatch Date: 2025-10-21

Publish Date: 2025-10-23

Submission Date: 2025-11-06

Documents

Tender Notice
Login to view

Corresponding contract award notice

Similar tenders

Belgium Public Procurement Intelligence

Frequently asked questions

The bid deadline for Antitumor Drugs was 06 Nov 2025. Bidding is closed.

This tender has been issued by CHIREC in Belgium.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 128739864. The purchaser document reference is 701736-2025.

See the Similar Tenders section on this page or browse other tenders from Belgium.

This tender falls under Materials and Products, Technology and Equipment in Belgium. Suppliers in these sectors can track similar Belgium tenders using CPV-based alerts.